GMED
Price
$58.59
Change
-$0.23 (-0.39%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
7.19B
34 days until earnings call
VREX
Price
$8.59
Change
+$0.05 (+0.59%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
732.76M
39 days until earnings call
Interact to see
Advertisement

GMED vs VREX

Header iconGMED vs VREX Comparison
Open Charts GMED vs VREXBanner chart's image
Globus Medical
Price$58.59
Change-$0.23 (-0.39%)
Volume$7.57K
Capitalization7.19B
Varex Imaging
Price$8.59
Change+$0.05 (+0.59%)
Volume$8.36K
Capitalization732.76M
GMED vs VREX Comparison Chart in %
Loading...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VREX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GMED vs. VREX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a StrongBuy and VREX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (GMED: $58.82 vs. VREX: $8.54)
Brand notoriety: GMED and VREX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GMED: 85% vs. VREX: 99%
Market capitalization -- GMED: $7.19B vs. VREX: $732.76M
GMED [@Medical Specialties] is valued at $7.19B. VREX’s [@Medical Specialties] market capitalization is $732.76M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green whileVREX’s FA Score has 0 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • VREX’s FA Score: 0 green, 5 red.
According to our system of comparison, VREX is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 4 TA indicator(s) are bullish while VREX’s TA Score has 6 bullish TA indicator(s).

  • GMED’s TA Score: 4 bullish, 3 bearish.
  • VREX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VREX is a better buy in the short-term than GMED.

Price Growth

GMED (@Medical Specialties) experienced а +2.53% price change this week, while VREX (@Medical Specialties) price change was +11.34% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +1.30%, and the average quarterly price growth was -0.29%.

Reported Earning Dates

GMED is expected to report earnings on Jul 31, 2025.

VREX is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($7.19B) has a higher market cap than VREX($733M). GMED has higher P/E ratio than VREX: GMED (49.65) vs VREX (18.22). GMED YTD gains are higher at: -28.884 vs. VREX (-41.467). GMED has higher annual earnings (EBITDA): 347M vs. VREX (85.6M). GMED has more cash in the bank: 518M vs. VREX (141M). VREX has less debt than GMED: VREX (470M) vs GMED (520M). GMED has higher revenues than VREX: GMED (1.57B) vs VREX (878M).
GMEDVREXGMED / VREX
Capitalization7.19B733M981%
EBITDA347M85.6M405%
Gain YTD-28.884-41.46770%
P/E Ratio49.6518.22272%
Revenue1.57B878M179%
Total Cash518M141M367%
Total Debt520M470M111%
FUNDAMENTALS RATINGS
GMED vs VREX: Fundamental Ratings
GMED
VREX
OUTLOOK RATING
1..100
5714
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
88100
SMR RATING
1..100
8492
PRICE GROWTH RATING
1..100
8365
P/E GROWTH RATING
1..100
9843
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GMED's Valuation (79) in the Medical Specialties industry is in the same range as VREX (85). This means that GMED’s stock grew similarly to VREX’s over the last 12 months.

GMED's Profit vs Risk Rating (88) in the Medical Specialties industry is in the same range as VREX (100). This means that GMED’s stock grew similarly to VREX’s over the last 12 months.

GMED's SMR Rating (84) in the Medical Specialties industry is in the same range as VREX (92). This means that GMED’s stock grew similarly to VREX’s over the last 12 months.

VREX's Price Growth Rating (65) in the Medical Specialties industry is in the same range as GMED (83). This means that VREX’s stock grew similarly to GMED’s over the last 12 months.

VREX's P/E Growth Rating (43) in the Medical Specialties industry is somewhat better than the same rating for GMED (98). This means that VREX’s stock grew somewhat faster than GMED’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMEDVREX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 18 days ago
66%
Bullish Trend 2 days ago
63%
Declines
ODDS (%)
Bearish Trend 10 days ago
57%
Bearish Trend 10 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VREX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
INQQ16.560.24
+1.49%
INQQ The India Internet ETF
NULG92.260.59
+0.64%
Nuveen ESG Large-Cap Growth ETF
ETX18.040.02
+0.11%
EATON VANCE Municipal Income 2028 TERM TRUST
LQDH92.010.02
+0.02%
iShares Interest Rate Hedged Corp Bd ETF
SCHD26.39-0.09
-0.34%
Schwab US Dividend Equity ETF™

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with CTKB. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then CTKB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
+1.08%
CTKB - GMED
46%
Loosely correlated
+6.61%
VREX - GMED
44%
Loosely correlated
+5.04%
CVRX - GMED
44%
Loosely correlated
+0.51%
WRBY - GMED
41%
Loosely correlated
-1.42%
GKOS - GMED
41%
Loosely correlated
+1.76%
More

VREX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VREX has been loosely correlated with NVST. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VREX jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VREX
1D Price
Change %
VREX100%
+5.04%
NVST - VREX
51%
Loosely correlated
+1.55%
ATR - VREX
50%
Loosely correlated
+0.36%
A - VREX
46%
Loosely correlated
+0.67%
ALGN - VREX
45%
Loosely correlated
+0.62%
IRMD - VREX
45%
Loosely correlated
+0.51%
More